KEAP1 and ovarian carcinoma: A significant association between the ROS suppressant KEAP-1 and ovarian cancer was shown in vitro via genotyping single-nucleotide polymorphisms (SNPs) within KEAP-1 expressed from cancerous epithelial ovarian cells [123].